Notably, the pronounced activation of the PI3K‐Akt signalling pathway may contribute to AD progression by modulating cell survival and vascular remodelling, while the enrichment of pathways related to lipid and atherosclerosis suggests a potential association between metabolic dysregulation and endothelial injury (Figure 2D). This evidence concerns the gene AKT1 and Alzheimer disease.